Pricing and Market Access in China: How Medtechs can Succeed

Published on January 19, 2023

The policy and market of medical devices are evolving rapidly in China. To tackle the upcoming challenges and achieve sustainable business excellence in the country, medtech companies will have to build up integrated market access capabilities. Experts Bruce Liu and Kathy Xu explain how.

Since the National Healthcare Security Administration (NHSA) established the first reimbursement policy for medical consumables in June 2020, we have witnessed drastic changes within the medtech market. As such, we advise medtech manufacturers to adopt more detailed and intricate pricing and market access (P&MA) strategies according to the lifecycle of medical devices.

Manufacturers should develop different sets of P&MA capabilities in different stages, including product early access, out-of-pocket (OOP) / alternative financing, basic medical insurance (BMI) coverage, and volume-based procurement (VoBP).

As seen in the…

Continue reading on website
Other news

„Apps auf Rezept“ und der GKV-SV: Wie sich DiGA-Hersteller auf Preisverhandlungen vorbereiten können

January 19, 2023
Rund anderthalb Jahre lang können in Deutschland nun DiGAs auf Rezept verordnet und durch die gesetzlichen Krankenkassen erstattet werden. Dafür müssen sich DiGA-Hersteller und der Spitzenverband der GKV in Verhandlungen auf einen Preis einigen. Kommt keine Einigung zustande, entscheidet eine Schiedsstelle über den…

The 8 Dos and Don’ts of Dynamic Pricing

January 19, 2023
Dynamic pricing is one of the most exciting topics in the pricing world right now. With digitalization providing many great business opportunities, companies are becoming more responsive with their pricing. But despite its technological underpinnings, dynamic pricing requires strong human oversight directed by a clear strategy.Dynamic pricing is certainly not new. It was pioneered by airlines in t